TY - JOUR
T1 - Importance of left atrial pressure during ex vivo lung perfusion
AU - Linacre, Virginia
AU - Cypel, Marcelo
AU - Machuca, Tiago
AU - Nakajima, Daisuke
AU - Hashimoto, Kohei
AU - Zamel, Ricardo
AU - Chen, Manyin
AU - Iskender, Ilker
AU - Dos Santos, Pedro
AU - Waddell, Thomas K.
AU - Liu, Mingyao
AU - Keshavjee, Shaf
N1 - Funding Information:
This research was supported by the Canadian Institutes of Health Research (OOP Grant 312227). XVIVO Perfusion (Sweden) provided the Steen Solution and EVLP circuits for this study.
Publisher Copyright:
© 2016 International Society for Heart and Lung Transplantation. All rights reserved.
PY - 2016/6/1
Y1 - 2016/6/1
N2 - Background Ex vivo lung perfusion (EVLP) allows for the evaluation and treatment of donor lungs before transplant. Different EVLP strategies have been described using either an open left atrium (LA) (pressure of 0 mm Hg) or closed LA (pressure of 5 mm Hg). We hypothesized that maintaining a physiologic positive LA pressure during EVLP is protective to the lung. Methods Pig lungs were flushed with Perfadex, retrieved and stored at 4°C for 4 hours [short cold ischemic time (CIT), n = 10] or 18 hours (prolonged CIT, n = 8). Subsequently, lungs underwent normothermic EVLP for 12 hours using either an open or closed LA technique. A linear mixed effect model was used to compare functional parameters between the 2 groups. Results After short CIT, 12-hour EVLP could not be completed in 4 of 5 open atrium cases due to significant pulmonary edema. Lung injury was evident in this group after 7 hours of EVLP, demonstrating an increase in pulmonary vascular resistance (p < 0.001) and peak inspiratory pressure (p = 0.001), and a decrease in lung compliance (p < 0.001) and perfusate oxygenation (p = 0.04). In contrast, in the closed atrium group, all lungs completed 12 hours of EVLP with stable functional parameters. At the end of the experiment, the wet/dry ratio (p = 0.015) and lung edema score (p = 0.02) were significantly worse in the open LA group compared with the closed LA EVLP group. Similar findings were observed in the prolonged CIT group. Conclusion The use of a closed atrial technique to create a controlled positive LA during EVLP leads to significantly less edema and superior lung physiology.
AB - Background Ex vivo lung perfusion (EVLP) allows for the evaluation and treatment of donor lungs before transplant. Different EVLP strategies have been described using either an open left atrium (LA) (pressure of 0 mm Hg) or closed LA (pressure of 5 mm Hg). We hypothesized that maintaining a physiologic positive LA pressure during EVLP is protective to the lung. Methods Pig lungs were flushed with Perfadex, retrieved and stored at 4°C for 4 hours [short cold ischemic time (CIT), n = 10] or 18 hours (prolonged CIT, n = 8). Subsequently, lungs underwent normothermic EVLP for 12 hours using either an open or closed LA technique. A linear mixed effect model was used to compare functional parameters between the 2 groups. Results After short CIT, 12-hour EVLP could not be completed in 4 of 5 open atrium cases due to significant pulmonary edema. Lung injury was evident in this group after 7 hours of EVLP, demonstrating an increase in pulmonary vascular resistance (p < 0.001) and peak inspiratory pressure (p = 0.001), and a decrease in lung compliance (p < 0.001) and perfusate oxygenation (p = 0.04). In contrast, in the closed atrium group, all lungs completed 12 hours of EVLP with stable functional parameters. At the end of the experiment, the wet/dry ratio (p = 0.015) and lung edema score (p = 0.02) were significantly worse in the open LA group compared with the closed LA EVLP group. Similar findings were observed in the prolonged CIT group. Conclusion The use of a closed atrial technique to create a controlled positive LA during EVLP leads to significantly less edema and superior lung physiology.
KW - donor lungs
KW - ex vivo lung perfusion
KW - left atrium pressure
KW - lung transplantation
KW - pulmonary edema
UR - http://www.scopus.com/inward/record.url?scp=84965049943&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84965049943&partnerID=8YFLogxK
U2 - 10.1016/j.healun.2016.02.008
DO - 10.1016/j.healun.2016.02.008
M3 - Article
C2 - 27160496
AN - SCOPUS:84965049943
SN - 1053-2498
VL - 35
SP - 808
EP - 814
JO - Journal of Heart and Lung Transplantation
JF - Journal of Heart and Lung Transplantation
IS - 6
ER -